Welcome to this startup showcase, where we highlight Viroclinics Biosciences, a contract research and clinical laboratory service company that provides diagnostic and preclinical studies for the biopharmaceutical community. With its extensive experience in respiratory viruses, in particular influenza, Viroclinics Biosciences is on a mission to improve human and animal health through its state-of-the-art diagnostics, custom-made models in (pre)clinical drug testing, and expert advice on development of antivirals and vaccines. In this showcase, we take a closer look at how Viroclinics Biosciences is advancing virus research and drug development.
Diagnostic and Preclinical Studies
Viroclinics Biosciences offers a full range of virology services for new drug development programs and post-marketing surveillance of existing drugs and vaccines. The company’s services range from traditional virology assays to the latest deep sequencing protocols for a broad range of viruses. The company’s BSL2 and BSL3 labs enable it to perform analysis according to international ISO 15189 accreditation, providing accurate and reliable results.
Viroclinics Biosciences’ expertise in virus research and drug development goes beyond its diagnostic and preclinical studies. The company also provides expert advice on the development of antivirals and vaccines, helping biopharmaceutical companies make informed decisions on the best path forward. By leveraging its extensive experience in respiratory viruses, in particular influenza, Viroclinics Biosciences is uniquely positioned to provide valuable insights into the development of effective antivirals and vaccines.
Custom-Made Models in (Pre)Clinical Drug Testing
In addition to its diagnostic and preclinical studies, Viroclinics Biosciences offers custom-made models in (pre)clinical drug testing. The company’s expertise in virus research enables it to develop models that accurately replicate human and animal responses to viral infections. These models are essential for the development and testing of effective antivirals and vaccines. With Viroclinics Biosciences’ custom-made models, biopharmaceutical companies can make informed decisions on which drugs and vaccines to move forward with, ultimately improving human and animal health.
Conclusion
In conclusion, Viroclinics Biosciences is a contract research and clinical laboratory service company that is advancing virus research and drug development. Through its state-of-the-art diagnostics, custom-made models in (pre)clinical drug testing, and expert advice on development of antivirals and vaccines, Viroclinics Biosciences is improving human and animal health. Its extensive experience in respiratory viruses, in particular influenza, makes it a valuable partner for biopharmaceutical companies looking to develop effective antivirals and vaccines.
Website: http://www.viroclinics.com
Want to amplify your startup’s story? EU Startup News is your launchpad to reach startup founders, investors, and C-level execs across Europe. Discover our tailored promotional strategies such as Sponsored Articles and Partnerships. Click here to learn more or contact us directly at [email protected]. Join us, and let’s make your startup the talk of Europe!
